Positive Psychiatry - with Rakesh Jain, MD

Positive Psychiatry and Two Forgotten Antidepressants

41 min · I går
episode Positive Psychiatry and Two Forgotten Antidepressants cover

Beskrivelse

Your patient tells you, “The darkness is gone… but the color is gone too.” That line captures a problem many of us recognize: symptom scores can look great while real life still feels flat. From Texas, I walk through the positive psychiatry question that keeps nagging at clinicians and patients alike: are we only stopping the storm, or are we helping people experience the full spectrum of their lives again?  We get specific about the “SSRI blight” and why emotional blunting, apathy, and cognitive fog can linger even when PHQ-9 and GAD-7 say “remission.” I argue for expanding our outcomes beyond symptom reduction to measures that reflect functioning and flourishing: focus, executive function, relationships, hobbies, resilience, and joy. That’s where the “forgotten antidepressants” come back into view.  We shine a spotlight on vortioxetine (Trintellix) as a multimodal antidepressant with receptor activity that may support cognitive clarity and executive functioning for the right patient, and we break down vilazodone (Viibryd) as a SPARI with a more calibrated serotonergic signal that can be a strong fit for anxious depression and rumination. We also talk honestly about the GI side effects that scare people off, and how practical steps like slower titration, patient education, and taking vilazodone with a substantial meal can make a real difference.  Clinicians and patients are both motivated to find the tools that move us from “better” to truly “well.” www.JainUplift.com

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Positive Psychiatry - with Rakesh Jain, MD-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

21 episoder

episode Positive Psychiatry and Two Forgotten Antidepressants cover

Positive Psychiatry and Two Forgotten Antidepressants

Your patient tells you, “The darkness is gone… but the color is gone too.” That line captures a problem many of us recognize: symptom scores can look great while real life still feels flat. From Texas, I walk through the positive psychiatry question that keeps nagging at clinicians and patients alike: are we only stopping the storm, or are we helping people experience the full spectrum of their lives again?  We get specific about the “SSRI blight” and why emotional blunting, apathy, and cognitive fog can linger even when PHQ-9 and GAD-7 say “remission.” I argue for expanding our outcomes beyond symptom reduction to measures that reflect functioning and flourishing: focus, executive function, relationships, hobbies, resilience, and joy. That’s where the “forgotten antidepressants” come back into view.  We shine a spotlight on vortioxetine (Trintellix) as a multimodal antidepressant with receptor activity that may support cognitive clarity and executive functioning for the right patient, and we break down vilazodone (Viibryd) as a SPARI with a more calibrated serotonergic signal that can be a strong fit for anxious depression and rumination. We also talk honestly about the GI side effects that scare people off, and how practical steps like slower titration, patient education, and taking vilazodone with a substantial meal can make a real difference.  Clinicians and patients are both motivated to find the tools that move us from “better” to truly “well.” www.JainUplift.com

I går41 min
episode GLP-1 Meds & Positive Psychiatry - A Deep Science Dive For Clinicians cover

GLP-1 Meds & Positive Psychiatry - A Deep Science Dive For Clinicians

GLP-1 medications are everywhere right now, but the most important conversation might be the one we are not having loudly enough: what do GLP-1 receptor agonists do to the brain? I go full geek mode on the neurobiology behind incretin mimetics and why semaglutide and tirzepatide may end up mattering to psychiatry as much as they matter to endocrinology. We start with anatomy and access. Endogenous GLP-1 is produced in the gut, but it is also produced by neurons in the brainstem and projected into regions that shape mood, anxiety, memory, and reward. From there, we explore how exogenous GLP-1 drugs can influence the central nervous system through selective blood-brain barrier entry points and vagal afferent pathways, and why receptor “real estate” in the hippocampus, amygdala, VTA, and nucleus accumbens changes the clinical story. Then we dive into mechanisms that matter for positive psychiatry: intracellular signaling (cAMP, kinases, CREB), neurotrophic support through BDNF, and the promise of neuroplasticity as more than a buzzword. We also unpack neuroinflammation and microglia, including how GLP-1 signaling may suppress inflammatory cascades, reduce oxidative stress, and create conditions where cognition and emotional regulation can recover. Finally, we connect GLP-1 to “food noise,” maladaptive salience, and dopamine spiking, highlighting how better top-down executive control could translate into real-world agency without blunting joy in most individuals. www.JainUplift.com

1. juli 202643 min
episode GABA: Positive Psychiatry's Unsung Key To Quieting Mental Static cover

GABA: Positive Psychiatry's Unsung Key To Quieting Mental Static

Your brain doesn’t just need more “happy chemicals.” It needs stability. We zoom in on GABA, the primary inhibitory neurotransmitter, and make the case that it’s one of the most overlooked keys to calm, clarity, resilience, and true mental health. We break down the neurobiology without the fluff: how GABA is made through the GABA shunt, how GABA-A and GABA-B receptors shape phasic and tonic inhibition, and why the excitatory-inhibitory balance between glutamate and GABA forms the functional backbone of the brain. From there, we connect the science to lived experience through the idea of “network flurry” the noisy, overdriven brain state that can show up in major depression, generalized anxiety, panic, PTSD, chronic stress, and the feeling that your mind simply won’t shut off. We also get practical about treatment. We examine how benzodiazepines and Z-drugs amplify GABA-A signaling, why they can bring fast relief, and why tolerance, dependence, sedation, and cognitive effects can work against long-term flourishing for many people. We clarify what gabapentin and pregabalin actually do (they are not direct GABA receptor drugs), then explore the emerging promise of neuroactive steroids like allopregnanolone and medications such as brexanolone and zuranolone for rapid antidepressant effects, including postpartum depression. To round it out, we highlight non-medication tools that support GABA function: mindfulness meditation, prayer, yoga, structured breath work like box breathing, exercise, and nutrition that supports healthy neurotransmitter synthesis. Let's hink differently about anxiety, depression, sleep, or stress. www.JainUplift.com

21. juni 202642 min
episode Journal Club: A New Wave In Positive Psychiatry With Four Landmark Journal Articles cover

Journal Club: A New Wave In Positive Psychiatry With Four Landmark Journal Articles

We launch a 'Psychiatry Journal Club' series built to get us reading again and to translate major psychiatry papers into practical, humane care.  We walk through four landmark studies that reshape how we think about schizophrenia treatment, suicidal crisis care, metabolic health, and relapse prevention through a Positive Psychiatry lens.  • why dopamine-first antipsychotics often miss negative symptoms and cognition while harming metabolic health  • how xanomeline plus trospium (KarXT/Cobenfy) targets M1 and M4 muscarinic receptors without direct D2 binding  • what the Emergent 3 phase 3 trial shows on PANSS change, onset by week two, and a cleaner metabolic and EPS profile  • why preserving reward circuitry and reducing dysphoria can change adherence conversations in schizophrenia  • the clinical gap between acute suicidality and multi-week SSRI and SNRI latency  • how intranasal esketamine rapidly affects glutamate circuits, AMPA signaling, mTORC1, and BDNF-driven synaptogenesis  • Aspire 2 outcomes at four hours and 24 hours, plus monitoring for dissociation and blood pressure changes  • how GLP-1 receptor agonists can reverse antipsychotic-induced weight gain and improve BMI, waist circumference, glucose, and lipids  • brain-gut-reward and neuroinflammation pathways that connect GLP-1s to neuropsychiatry  • why early long-acting injectables reduce relapse risk, hospitalizations, and functional decline in early schizophrenia  • how relapse biology and oral medication level swings support a neuroprotection argument for LAIs  Let’s together keep reading. We must read more, folks.  www.JainUplift.com

14. juni 202659 min
episode Resilience and Positive Psychiatry - Practical Tips and Suggestions For Optimization cover

Resilience and Positive Psychiatry - Practical Tips and Suggestions For Optimization

Your brain is built to detect danger fast, but it is also built to learn, adapt, and recover. We explore resilience through the lens of positive psychiatry and modern neuroscience, starting with a simple image: a three-story house in the mind. The basement is the amygdala, your smoke alarm. The second floor is the hippocampus, your memory librarian. The penthouse is the prefrontal cortex, the executive center that brings logic, planning, and emotional regulation back online. Resilience is not “never feeling stress.” It’s how quickly and smoothly your executive brain can send an all-clear signal when life hits. From there, we get concrete. We walk through the science of neuroplasticity and why BDNF, brain-derived neurotrophic factor, matters for building a more resilient brain over time. Then we lay out five biological pillars that act like a protective shield for your nervous system: optimized sleep, mindful movement, targeted nutrition through the gut-brain axis, mindfulness and meditation to reduce rumination, and deep social connection to buffer stress physiology. You’ll also hear why trying to change everything at once can trigger burnout, and how to pace your habits so they actually stick. Finally, we share a practical tool you can use when the walls feel like they’re closing in: the ABCDE cognitive model (Adversity, Belief, Consequences, Disputation, Energize). We connect it to the bigger goal of post-traumatic growth: not just bouncing back, but bouncing higher with deeper relationships, clearer priorities, new possibilities, stronger inner confidence, and meaningful spiritual change. www.JainUplift.com

7. juni 202640 min